Inspire Investing LLC Takes Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Inspire Investing LLC acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 37,670 shares of the company’s stock, valued at approximately $791,000. Inspire Investing LLC owned 0.09% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. BNP Paribas Financial Markets lifted its stake in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the last quarter. SG Americas Securities LLC lifted its stake in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares during the last quarter. Public Sector Pension Investment Board lifted its stake in Phibro Animal Health by 6.1% during the second quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company’s stock worth $751,000 after purchasing an additional 2,583 shares during the last quarter. Finally, Segall Bryant & Hamill LLC lifted its stake in Phibro Animal Health by 1.7% during the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock worth $3,931,000 after purchasing an additional 2,971 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, January 12th. Finally, Barclays boosted their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $21.91 on Friday. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98. The stock has a 50 day moving average of $22.15 and a two-hundred day moving average of $21.35. The stock has a market cap of $887.42 million, a P/E ratio of 50.95, a P/E/G ratio of 0.56 and a beta of 0.53.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.12. The business had revenue of $260.40 million for the quarter, compared to analyst estimates of $277.76 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. During the same quarter in the previous year, the company posted $0.14 earnings per share. On average, research analysts forecast that Phibro Animal Health Co. will post 1.62 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s payout ratio is currently 111.63%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.